Waldencast Acquisition Corp (WALD) - Net Assets
Based on the latest financial reports, Waldencast Acquisition Corp (WALD) has net assets worth $500.10 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($816.20 Million) and total liabilities ($316.10 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Waldencast Acquisition Corp asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $500.10 Million |
| % of Total Assets | 61.27% |
| Annual Growth Rate | N/A |
| 5-Year Change | 1174.49% |
| 10-Year Change | N/A |
| Growth Volatility | 845.31 |
Waldencast Acquisition Corp - Net Assets Trend (2020–2025)
This chart illustrates how Waldencast Acquisition Corp's net assets have evolved over time, based on quarterly financial data. Also explore Waldencast Acquisition Corp assets under control for the complete picture of this company's asset base.
Annual Net Assets for Waldencast Acquisition Corp (2020–2025)
The table below shows the annual net assets of Waldencast Acquisition Corp from 2020 to 2025. For live valuation and market cap data, see Waldencast Acquisition Corp (WALD) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $500.10 Million | -31.49% |
| 2024-12-31 | $729.94 Million | -5.11% |
| 2023-12-31 | $769.27 Million | -3.83% |
| 2022-12-31 | $799.90 Million | +1938.53% |
| 2021-12-31 | $39.24 Million | +358414.31% |
| 2020-12-31 | $-10.95K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Waldencast Acquisition Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 51894204900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $13.00K | 0.00% |
| Other Comprehensive Income | $-378.00K | -0.08% |
| Other Components | $981.20 Million | 212.44% |
| Total Equity | $461.88 Million | 100.00% |
Waldencast Acquisition Corp Competitors by Market Cap
The table below lists competitors of Waldencast Acquisition Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Calitech Co Ltd
TWO:6532
|
$113.73 Million |
|
Celik Halat ve Tel Sanayi AS
IS:CELHA
|
$113.80 Million |
|
Diploma PLC
LSE:DPLM
|
$113.80 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
$113.83 Million |
|
Seer Inc
NASDAQ:SEER
|
$113.63 Million |
|
Fino Payments Bank Limited
NSE:FINOPB
|
$113.59 Million |
|
CVW CleanTech Inc
V:CVW
|
$113.57 Million |
|
ActRO Co. Ltd
KQ:290740
|
$113.49 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Waldencast Acquisition Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 662,319,000 to 461,879,000, a change of -200,440,000 (-30.3%).
- Net loss of 229,749,000 reduced equity.
- Other comprehensive income decreased equity by 629,000.
- Other factors increased equity by 29,938,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-229.75 Million | -49.74% |
| Other Comprehensive Income | $-629.00K | -0.14% |
| Other Changes | $29.94 Million | +6.48% |
| Total Change | $- | -30.26% |
Book Value vs Market Value Analysis
This analysis compares Waldencast Acquisition Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.24x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $0.00 | $0.96 | x |
| 2021-12-31 | $0.90 | $0.96 | x |
| 2022-12-31 | $7.44 | $0.96 | x |
| 2023-12-31 | $6.17 | $0.96 | x |
| 2024-12-31 | $6.06 | $0.96 | x |
| 2025-12-31 | $4.05 | $0.96 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Waldencast Acquisition Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -49.74%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -84.44%
- • Asset Turnover: 0.33x
- • Equity Multiplier: 1.77x
- Recent ROE (-49.74%) is below the historical average (-24.09%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 0.00% | -2.51% | 566.14x | 0.00x | $-2.37 Million |
| 2021 | -49.89% | -13.74% | 0.77x | 4.70x | $-23.50 Million |
| 2023 | -14.41% | -41.25% | 0.21x | 1.67x | $-152.44 Million |
| 2024 | -6.41% | -15.50% | 0.28x | 1.47x | $-108.67 Million |
| 2025 | -49.74% | -84.44% | 0.33x | 1.77x | $-275.94 Million |
Industry Comparison
This section compares Waldencast Acquisition Corp's net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $1,363,927,605
- Average return on equity (ROE) among peers: -469.05%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Waldencast Acquisition Corp (WALD) | $500.10 Million | 0.00% | 0.63x | $113.64 Million |
| Acme United Corporation (ACU) | $6.50 Million | -49.23% | 3.20x | $159.26 Million |
| Bruush Oral Care Inc. (BRSHF) | $163.14K | -5449.60% | 11.70x | $10.10K |
| Park Ha Biological Technology Co., Ltd. (BYAH) | $150.28K | 127.30% | 15.76x | $12.69 Million |
| Church & Dwight Company Inc (CHD) | $2.04 Billion | 15.17% | 0.53x | $22.73 Billion |
| Colgate-Palmolive Company (CL) | $243.00 Million | 832.92% | 51.16x | $70.34 Billion |
| The Clorox Company (CLX) | $297.00 Million | 218.18% | 14.21x | $10.53 Billion |
| Coty Inc (COTY) | $9.87 Billion | -4.28% | 1.28x | $1.95 Billion |
| Carmell Therapeutics Corporation (CTCX) | $-37.79 Million | 0.00% | 0.00x | $4.61 Million |
| Big Tree Cloud Holdings Limited Ordinary Shares (DSY) | $453.17K | -417.72% | 4.36x | $19.52 Million |
| Estee Lauder Companies Inc (EL) | $1.22 Billion | 36.81% | 2.38x | $19.60 Billion |
About Waldencast Acquisition Corp
Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand. The company operates through two segments, Obagi Medical and Milk Makeup. It offers skin care products to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and protect and enhance skin tone and texture; co… Read more